Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
ENOV
)
46.17
+1.39 (+3.10%)
Official Closing Price
Updated: 7:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ENOV
< Previous
1
2
3
4
Next >
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 07, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
January 29, 2024
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio.
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
January 26, 2024
From
Enovis Corporation
Via
GlobeNewswire
The Analyst Landscape: 6 Takes On Enovis
January 08, 2024
Via
Benzinga
Analyst Ratings for Enovis
December 15, 2023
Via
Benzinga
4 Analysts Have This to Say About Enovis
October 20, 2023
Via
Benzinga
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
January 25, 2024
The newest innovation in unloader braces is comfortable, easy to use and effective.
From
Enovis Corporation
Via
GlobeNewswire
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
January 03, 2024
William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth,...
Via
Benzinga
Enovis Completes Acquisition of LimaCorporate S.p.A
January 03, 2024
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From
Enovis Corporation
Via
GlobeNewswire
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
December 15, 2023
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising
Via
Benzinga
Enovis Announces Business Segment Leadership Transition Plan
December 05, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference
November 16, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook
November 07, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting
October 30, 2023
Company unveils new ARVIS® augmented reality system, the EMPOWR™ blade stem and more at upcoming conference in Texas
From
Enovis Corporation
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
October 20, 2023
Via
Benzinga
ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028
October 20, 2023
From
Enovis Corporation
Via
GlobeNewswire
Why Enovis Stock Is Trading Lower Today
October 19, 2023
Enovis Corporation (NYSE: ENOV) shares are trading lower on Thursday after the company announced a proposed private offering of $400 million of convertible senior notes and issued
Via
Benzinga
Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023
October 19, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes
October 19, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host Third Quarter 2023 Results Conference Call on November 7th
October 16, 2023
From
Enovis Corporation
Via
GlobeNewswire
Big Moves In Orthopedics: Enovis Seals €800M Deal To Acquire LimaCorporate
September 25, 2023
Enovis Corp (NYSE: ENOV) inked a deal to acquire LimaCorporate S.p.A. for an
Via
Benzinga
Enovis to Acquire LimaCorporate S.p.A.
September 25, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
September 18, 2023
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and Patient Specific Instrumentation, will be featured as part of the company’s growing evidence based, high tech...
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
August 08, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Announces Second Quarter 2023 Results and Raises Full-Year Outlook
August 03, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis to Host Second Quarter 2023 Results Conference Call on August 3rd
July 11, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis™ Recognized as One of America’s Greatest Workplaces 2023 by Newsweek
July 06, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis™ Completes Acquisition of Novastep®
June 28, 2023
From
Enovis Corporation
Via
GlobeNewswire
Enovis Above-Market Growth Potential Surge Would Come from Market Share Gains and Accretive Acquisitions: Analyst
June 26, 2023
Needham initiated coverage on Enovis Corp (NYSE: ENOV) with a Buy and a price target of $70, noting that the company can sustain above-market growth in its Reconstructive segment via market share gains...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.